Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

DEVICE USER FEES OF $105,000 FOR PMAs AND PLAs, $5,900 FOR 510(K)s PROPOSED IN DRAFT BILL; SPONSORS OF PENDING APPLICATIONS WOULD BE ASSESSED HALF PRICE

This article was originally published in The Gray Sheet

Executive Summary

Device submission user fees would be set at $105,000 for premarket approval and product license applications and $5,900 for 510(k)s under an April 12 discussion draft of user fee legislation formulated by the majority staff of the House Energy and Commerce Committee. The draft would set fees of $55,000 for premarket approval supplements that include required clinical data and $5,900 for PMA supplements without clinical data.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT002168

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel